Synergistic Action of Gefitinib and GSK41364A Simultaneously Loaded in Ratiometrically-Engineered Polymeric Nanoparticles for Glioblastoma Multiforme

Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles

(2018) Fred C. Lam et al.   Nature Communications

Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 (BRCA2) Mutation

(2018) Chong Du et al.   ACS Nano

Ratiometric co-delivery of multiple chemodrugs in a single nanocarrier

(2017) Chao Chen et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

(2017) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial

(2017) Ulrich Herrlinger et al.   NEURO-ONCOLOGY

β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway

(2016) Lin Mu et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

(2016) Cláudia Saraiva et al.   JOURNAL OF CONTROLLED RELEASE

Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy

(2016) Qian Chen et al.   Nature Communications

PEGylation in anti-cancer therapy: An overview

(2016) Prajna Mishra et al.   Asian Journal of Pharmaceutical Sciences

Nanoparticle colloidal stability in cell culture media and impact on cellular interactions

(2015) Thomas L. Moore et al.   CHEMICAL SOCIETY REVIEWS

Acute effects of surgery on emotion and personality of brain tumor patients: surgery impact, histological aspects, and recovery

(2015) Fabio Campanella et al.   NEURO-ONCOLOGY

Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance

(2015) Kimmo J. Hatanpaa et al.   NEOPLASIA

Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer

(2014) Lei Miao et al.   ADVANCED FUNCTIONAL MATERIALS

Advances in Combination Therapies Based on Nanoparticles for Efficacious Cancer Treatment: An Analytical Report

(2014) Serge Mignani et al.   BIOMACROMOLECULES

The epidemiology of glioma in adults: a "state of the science" review

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

p300/CBP dependent hyperacetylation of histone potentiates anticancer activity of gefitinib nanoparticles

(2013) Jasmine Kaur et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

(2013) R W F van Leeuwen et al.   BRITISH JOURNAL OF CANCER

Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma

(2013) J A Pezuk et al.   CANCER GENE THERAPY

Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation

(2013) Anita T. Tandle et al.   EUROPEAN JOURNAL OF CANCER

Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC

(2013) Yuan Zhang et al.   MOLECULAR THERAPY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

(2013) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110 

(2013) A. Schulte et al.   NEURO-ONCOLOGY

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

(2012) Roger Stupp et al.   EUROPEAN JOURNAL OF CANCER

Is dialysis a reliable method for studying drug release from nanoparticulate systems?—A case study

(2012) Y. Zambito et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

(2011) D. Olmos et al.   CLINICAL CANCER RESEARCH

Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease

(2011) Kaili Hu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation

(2011) Cheng-Yi Chang et al.   JOURNAL OF NEURO-ONCOLOGY

Improved survival time trends for glioblastoma using the SEER 17 population-based registries

(2011) Matthew Koshy et al.   JOURNAL OF NEURO-ONCOLOGY

Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy

(2011) Santosh Aryal et al.   MOLECULAR PHARMACEUTICS

DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles

(2010) Yong Zhang et al.   AAPS Journal

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers

(2009) Twan Lammers et al.   BIOMATERIALS

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

(2009) Massimo Di Maio et al.   JOURNAL OF CLINICAL ONCOLOGY

Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications

(2008) David E. Sosnovik et al.   BASIC RESEARCH IN CARDIOLOGY